Screen LibraryIntraperitoneal therapy for ovarian cancer
Saved in:
| Corporate Authors: | |
|---|---|
| Group Author: | ; ; ; |
| Published: |
Springer-Verlag,
|
| Publisher Address: | Dordrecht New York |
| Publication Dates: | c2010. |
| Literature type: | Book |
| Language: | English |
| Subjects: | |
| Online Access: |
http://dx.doi.org/10.1007/978-3-642-12130-2 |
| Carrier Form: | 1 online resource (viii, 153 p.): ill. (some col.) |
| ISBN: |
9783642121302 (electronic bk.) 3642121306 (electronic bk.) |
| Index Number: | R737 |
| CLC: | R737.31 |
| Contents: |
Includes bibliographical references and index. Current chemotherapy of ovarian cancer -- Principles of intraperitoneal chemotherapy -- Intraperitoneal chemotherapy: phase III trials -- Criteria for using intraperitoneal (IP) chemotherapy for advanced ovarian cancer -- Selection and placement of intraperitoneal catheters for IP chemotherapy for ovarian cancer -- Selection of drugs for intraperitoneal chemotherapy for ovarian cancer -- Administration guidelines for intraperitoneal chemotherapy for ovarian cancer -- Novel drugs for intraperitoneal therapy for ovarian cancer -- Cytoreductive surgery and perioperative intraperitoneal chemotherapy: an ongoing research effort -- Health-related quality of life and patient-reported outcomes. Intraperitoneal chemotherapy is increasingly being used as first-line treatment for ovarian cancer. Nevertheless, it is difficult for the oncologist to find a definitive text that documents both the fundamental methods required to optimize therapy and the up-to-date results of phase I, II, and III clinical trials. With this in mind, the editors of Intraperitoneal Chemotherapy have assembled a team of highly experienced clinicians and researchers to cover every aspect of the subject. The topics addressed include treatment principles, patient, drug, and catheter selection, administration guideli. |